Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Pulmonary Medicine

Reuters Health • The Doctor's Channel Daily Newscast

Progression of EGFR-mutated lung cancer slowed with first-line gefitinib

NEW YORK (Reuters Health) – Patients with non-small-cell lung cancer harboring susceptibility mutations in the epidermal growth factor receptor (EGFR) did better with gefitinib given as first-line therapy than with standard chemotherapy, in a randomized...

Reuters Health • The Doctor's Channel Daily Newscast

Older antibiotic as good as ciprofloxacin for severe acute COPD

NEW YORK (Reuters Health) – For patients with severe acute exacerbation of chronic obstructive pulmonary disease (COPD), trimethoprim-sulfamethoxazole was just as effective and safe as ciprofloxacin in a double-blind prospective trial conducted in...

Reuters Health • The Doctor's Channel Daily Newscast

PE risk factor assessment reduces need for CT angiograms

NEW YORK (Reuters Health) – By evaluating risk factors for thromboembolism, physicians can reduce the number of computed tomography (CT) angiograms they order for patients with suspected pulmonary embolism (PE), investigators report. “There’s...